COVID-19 Switzerland
Information on the current situation, as of 21 June 2022
Geographical distribution
Vaccinated people by canton of residence, Glarus, Status: 20.06.2022
The graph shows the share of vaccinated people by canton of residence for the selected age group. People who are resident outside Switzerland and the Principality of Liechtenstein, and those whose residence is not known, are shown separately.
The age groups presented correspond to the COVID-19 vaccination strategy.
The age groups presented correspond to the COVID-19 vaccination strategy.
The data published here is based on information provided to us regularly by the cantons and the Principality of Liechtenstein. We publish the numbers each Tuesday. Therefore, they may differ from the numbers communicated by the cantons and Liechtenstein. The figures cover vaccines from all manufacturers.
Three vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. People are deemed to be fully vaccinated if they have received two doses of Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) vaccine, or one dose of these vaccines after a proven infection with SARS-CoV-2. Only one dose of the Johnson & Johnson (Covid-19 Vaccine Janssen®) vaccine is required (FOPH/Federal Vaccination Commission vaccination recommendation).
A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) is recommended from four months following full vaccination (primary course of vaccination) for everyone aged 12 years or older (preferably Comirnaty® for those aged between 12 and 30 years). Fully vaccinated people who receive a booster vaccination in accordance with the FOPH/Federal Vaccination Commission vaccination recommendation are presented separately. The share of fully vaccinated people relates to the total population or the age group in question. Vaccinated people are allocated to the canton in which they live (canton of residence). More information can be found on FOPH website > Coronavirus: Vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website.
The cantons and the Principality of Liechtenstein provide us with the data via a secure electronic channel. They are sent in the form of anonymised individual data.
Three vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. People are deemed to be fully vaccinated if they have received two doses of Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) vaccine, or one dose of these vaccines after a proven infection with SARS-CoV-2. Only one dose of the Johnson & Johnson (Covid-19 Vaccine Janssen®) vaccine is required (FOPH/Federal Vaccination Commission vaccination recommendation).
A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) is recommended from four months following full vaccination (primary course of vaccination) for everyone aged 12 years or older (preferably Comirnaty® for those aged between 12 and 30 years). Fully vaccinated people who receive a booster vaccination in accordance with the FOPH/Federal Vaccination Commission vaccination recommendation are presented separately. The share of fully vaccinated people relates to the total population or the age group in question. Vaccinated people are allocated to the canton in which they live (canton of residence). More information can be found on FOPH website > Coronavirus: Vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website.
The cantons and the Principality of Liechtenstein provide us with the data via a secure electronic channel. They are sent in the form of anonymised individual data.